Study of the effectiveness of IFN-beta monotherapy for hemodialysis patients with chronic hepatitis C
Not Applicable
- Conditions
- chronic hepatitis C
- Registration Number
- JPRN-UMIN000011331
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of hypersensitivity to against bovine-derived material and IFN preparation Patients with chronic liver disease other autoimmune hepatitis, and alcoholic liver injury Patients with liver failure and cirrhosis Patients with abnormal thyroid function Patients receiving in the Sho-saiko Patient patient that may be pregnant or are pregnant, breast-feeding Patients with severe depression Patients with a history of hypersensitivity to any vaccine, such as biological products Other patients who tested physician has determined is inappropriate participate in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method